Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors.AuthorsMassard, Christophe; Margetts, Jane; Amellal, Nadia; Drew, Yvette; Bahleda, Ratislav; Stevens, Peter; Armand, Jean; Calvert, Hilary; Soria, Jean; Coronado, Cinthya; Kahatt, Carmen; Alfaro, Vicente; Siguero, Mariano; Fernández-Teruel, Carlos; Plummer, RuthPublicationInvestigational New Drugs, 2013, Vol 31, Issue 3, p623ISSN0167-6997Publication typeArticleDOI10.1007/s10637-012-9843-5